Genetic background determines inflammatory angiogenesis response to dipyridamole in mice

Experimental Biology and Medicine

Volumn 237, Issue 9, 2012, Pages 1084-1092

  Sampaio, Fernanda Portella ^a   Castro, Pollyana Ribeiro ^a   Marques, Suzane Mota ^a   Campos, Paula Peixoto ^a   Ferreira Ferreira, Mônica Alves Neves Diniz ^a   Andrade, Silvia Passos ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cytokine; Mouse strain; Sponge implant

Indexed keywords

COLLAGEN; DIPYRIDAMOLE; HEMOGLOBIN; MYELOPEROXIDASE; N ACETYL BETA GLUCOSAMINIDASE; NITRITE; POLYETHERURETHAN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ACETYLGLUCOSAMINIDASE; NITRIC OXIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; FIBRIN FORMATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; INFLAMMATION; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; SKIN BLOOD FLOW; CELL PROLIFERATION; COLLAGEN METABOLISM; GENETIC ANALYSIS; HISTOLOGY; IMPLANT; QUANTITATIVE ASSAY; SPONGE IMPLANT; TISSUE GROWTH;

ACETYLGLUCOSAMINIDASE; ANIMALS; BLOOD FLOW VELOCITY; COLLAGEN; DIPYRIDAMOLE; HEMOGLOBINS; INFLAMMATION; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE; NITRITES; PEROXIDASE; PHOSPHODIESTERASE INHIBITORS; SPECIES SPECIFICITY; SURGICAL SPONGES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTORS;

MUS;

EID: 84866443314     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2012.012066     Document Type: Article

References (29)

1. Sigmund CD. View point: are studies in genetically altered mice out of control? Arterioscler Thromb Vasc Biol 2000;20:1425-9
2. Schadt EE, Monks SA, Drake TA, Lusis AJ, Che N, Colinayo V, Ruff TC, Millingan SB, Lamb JR, Cavet G, Linsley PS, Mao M, Stoughton RB, Friend SH. Genetics of gene expression surveyed in maize, mouse and man. Nature 2003;422:297-302
3. Simopoulos AP. Genetic variantes in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol and Med 2010;235: 785-95
4. Donehower LA, Harvey M, Vogel H, McArthur MJ, Montgomery CA Jr, ark SA, Thompson T, Ford RJ, Bradley A. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 1995;14:16-22
5. Li X, Gu W, Masinde G, Hamilton-Ulland M, Xu S, Mohan S, Baylink DJ. Genetic control of the rate of wound healing in mice. Heredity 2001;86:668-74
6. Fukino K, Sata M, Seko Y, Hirata Y, Nagai R. Genetic Background influences therapeutic effectiveness of VEGF. Biochem and Biophys Res Commun 2003;310:143-7
7. Manigrasso MB, O'Connor JP. Comparison of fracture healing among different inbred mouse strains. Calcf Tissue Int 2008;8:465-74
8. Mansinde GL, Li R, Nguyen B, Yu H, Srivastava AK, Edderkaoui B, Wergedal JE, Baylink BJ, Mohan S. New quantitative trait loci that regulate wound healing in an intercross progeny from DBA/1J and 129 × 1SvJ inbred strains of mice. Funct Integr Genomics 2006;6:157-63
9. Pal-Ghosh S, Tadvalkar G, Jurjus RA, Zieske ID, Stepp MA. BALB/C and C57BL6 mouse strains vary in their ability to heal corneal epithelial debridement wounds. Exp Eye Res 2008;87:478-86
10. Van den Borne SW, Van de Schans VA, Strzelecka AE, Vervoort-Peters HT, Lijnen PM, Cleutjens JP, Smits JF, Daemen MJ, Janssen BJ, Blankesteijn WM. Mouse strain determines the outcome of wound healing after myocardial infarction. Cardiovasc Res 2009;84:273-82
11. Kolb M, Bonniaud P, Galt T, Sime PJ, Kelly MM, Margetts PJ, Gauldie J. Differences in fibrogenic responses after transfer of active transforming growth factor-b1 gene to lungs of 'fibrosis-prone' and 'fibrosis-resistant' mouse strains. Am J Respir Cell Mol Biol 2002;27:141-50
12. Chalothorn D, Clayton JA, Zhang H, Pomp D, Faber JE. Collateral density, remodeling, and VEGF-A expression differ widely between mouse strain. Physiol Genomics 2007;30:179-91
13. Gimenez-Conti IB, Bianchi AB, Fischer SM, Reiners JJ Jr, Conti CJ, Slaga TJ. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res 1992;52:3432-5
14. Rohan RM, Fernandez A, Udagawa T, Yuan J, D'amato RJ. Genetic heterogeneity of angiogenesis in mice. FASEB J 2000;14:871-6
15. Fitzgerald GA. Dypiridamole. N Engl J Med 1987;316:1247-57
16. Iimura O, Kusano E, Amemiya M, Muto S, Ikeda U, Shimada K, Asano Y. Dypiridamole enhances interleukin-1beta-stimulated nitric oxide production by cultured rat vascular smooth muscle cells. Eur J Pharmacol 1996;296:319-26
17. Hillis GS, Duthie LA, MacLeod AM. Dypiridamole inhibits human mesangial cell proliferation. Nephron 1998;78:172-8
18. Patillo CB, Bir SC, Branch BG, Greber E, Shen X, Pardue S, Patel RP, Kevil CG. Dipyridamole reverses peripheral ischemia and induces angiogenesis in the Db/Db diabetic mouse hind-limb model by decreasing oxidative stress. Free Radical Biol Med 2011;50:262-9
19. Marques SM, Campos PP, Castro PR, Cardoso CC, Ferreira MA, Andrade SP. Genetic background determines mouse strain differences in inflammatory angiogenesis. Microvasc Res 2011;82:246-52
20. Ferreira MAND, Barcelos LS, Campos PP, Vasconcelos AC, Teixeira MM, Andrade SP. Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO). Br J Pharmacol 2004; 141:1185-92
21. Mendes JB, Rocha MA, Araujo FA, Moura SA, Ferreira MA, Andrade SP. Differential effects of rolipram on chronic subcutaneous inflammatory angiogenesis and on peritoneal adhesion in mice. Microvasc Res 2009;78:265-71
22. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Stireter RM. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004;114:438-46
23. Campos PP, Bakhle YS, Andrade SP. Mechanisms of wound healing responses in lupus-prone New Zealand White mouse strain. Wound Rep Reg 2008;16:416-24
24. Green RM, Roedersheimer LR, DeWeese JA. Effects of aspirin and dypiridamole on expanded polytetrafluoroethylene graft patency. Surgery 1982;92:1016-26
25. Andrade SP, Machado RDP, Teixeira AS, Belo AV, Tarso AM, Beraldo WT. Sponge-induced angiogenesis in mice and the pharmacological reactivity of the neovasculature quantitated by a fluorimetric method. Microvasc Res 1997;54:253-61
26. Weyrich AS, Denis MM, Kuhlmann-Eyre JR, Spencer ED, Dixon DA, Marathe GK, Mclntyre TM, Zimmerman GA, Prescott SM. Dypiridamole selectively inhibits inflammatory gene expression in platelet-monocyte aggregates. Circulation 2005;111:633-42
27. Venkatesh PK, Pattillo CB, Branch B, Hood J, Thoma S, Illum S, Pardue S, Teng X, Patel RP, Kevil CG. Dypiridamole enhances ischaemia-induced arteriogenesis through an endocrine nitrite/nitric oxide-dependent pathway. Cardiovasc Res 2010;85:661-70
28. Belo AV, Leles F, Barcelos LS, Ferreira MA, Barkhle YS, Teixeira MM, Andrade SP. Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue. Microcirculation 2005;12:597-606
29. Hung KY, Shyu RS, Fang CC, Tsai CC, Lee PH, Tsai TJ, Hsieh BS. Dipyridamole inhibits human peritoneal mesothelial cell proliferation in vitro and attenuates rat peritoneal fibrosis in vivo. Kidney Int 2001;59:2316-24